{
  "variant_id": {
    "Gene": "EGFR",
    "Protein_Change": {
      "ref": "L",
      "alt": "R",
      "position": "858"
    },
    "variant_string_id": "EGFR L858R"
  },
  "functional_evidence_aim": "Pathogenic",
  "assessment_steps": [
    {
      "step_name": "Step 1: Define the disease mechanism",
      "extracted_paper_info": "The paper clearly defines that EGFR mutations, including L858R, are a known driver mutation in lung adenocarcinoma and are associated with response to targeted therapies.",
      "judgment": "Yes",
      "reasoning": "The disease mechanism is well-defined, as EGFR mutations are a critical driver of lung cancer pathogenesis."
    },
    {
      "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
      "extracted_paper_info": "The paper uses a cell viability assay to assess the effect of EGFR inhibitors on cells harboring the L858R mutation. This is a standard and relevant assay for evaluating drug response in oncology.",
      "judgment": "Yes",
      "reasoning": "The general class of assay (cell viability) effectively models the disease mechanism by assessing sensitivity to targeted therapies, which is directly tied to the known function of EGFR mutations.",
      "next_step_or_outcome": "Proceed to Step 3"
    },
    {
      "step_name": "Step 3: Evaluate validity of specific instances of assays",
      "extracted_paper_info": "The assay includes wild-type and mutant EGFR controls, with multiple replicates performed. Known pathogenic (e.g., L858R) and benign variants are used as positive and negative controls, respectively.",
      "judgment": "Yes",
      "reasoning": "Basic controls (wild-type and mutant) and replicates were included. Known pathogenic and benign variants were used as controls, ensuring the validity of the assay."
    },
    {
      "step_name": "Sub-step 3c: Variant Controls",
      "extracted_paper_info": "The paper uses known pathogenic variants (e.g., L858R) as positive controls and benign variants as negative controls.",
      "judgment": "Yes",
      "reasoning": "Variant controls were used, including known pathogenic and benign variants."
    },
    {
      "step_name": "Step 4: Apply evidence to individual variant interpretation",
      "extracted_paper_info": "The paper does not explicitly mention statistical analyses or provide an OddsPath value for the L858R variant. However, it includes multiple replicates and a sufficient number of control variants.",
      "judgment": "Yes",
      "reasoning": "No statistical analyses are reported, but the number of control variants (3 pathogenic and 3 benign) is less than 11."
    }
  ],
  "final_evidence_strength": {
    "type": "Pathogenic",
    "strength": "PS3_supporting"
  },
  "overall_conclusion": "The functional evidence for EGFR L858R supports its classification as pathogenic, with sufficient controls and replicates but without statistical analyses or a large number of control variants."
}